Table 1 Baseline clinical characteristics of patients with atrial fibrillation (AF) as compared to the control group
| Â | AF (41) n (%) | Controls (41) n (%) | P value |
|---|---|---|---|
Mean age (years) | 64.5 ± 4.0 | 61.7 ± 2.4 | 0.12 |
Sex (M/F) | 29/12 | 13/28 | <0.01 |
BMI (Kg/m2) | 32.5 ± 2.3 | 25.8 ± 1.6 | <0.01 |
Comorbid conditions: | |||
HTN | 30 (73.2) | 16 (39) | <0.01 |
CAD | 14 (34.1) | 4 (9.7) | <0.01 |
Systolic HF | 13 (31.7) | 0 | <0.01 |
CVA | 1 (2.4) | 0 | 1.0 |
DM | 11 (26.8) | 4 (9.7) | 0.08 |
Dyslipidemia | 24 (58.5) | 9 (21.9) | <0.01 |
Medications: | |||
Statins | 22 (53.6) | 6 (14.6) | <0.01 |
Beta blockers | 27 (65.8) | 9 (21.9) | <0.01 |
ACE-i/ARB | 24 (58.5) | 8 (19.5) | <0.01 |
CCB | 17 (41.5) | 5 (12.2) | <0.01 |
Digoxin | 4 (9.7) | 0 | 0.11 |
Diuretics | 21 (51.2) | 5 (12.2) | <0.01 |
ASA | 30 (73.2) | 5 (12.2) | <0.01 |
Clopidogrel | 2 (4.8) | 0 | 0.49 |
Warfarin | 28 (68.3) | 3 (7.3) | <0.01 |
Heparin | 4 (9.7) | 0 | 0.11 |
Amiodarone | 8 (19.5) | 0 | <0.01 |
Sotalol | 5 (12.2) | 0 | 0.05 |
Other anti-arrhythmics | 4 (9.7) | 0 | 0.11 |